Since JNK-specific inhibition prevents RTT synaptopathy and rescues behavioral and breathing defects, treatments that target the JNK pathway represent strong candidates against RTT and other neurodevelopmental disorders. This evidence concerns the gene MAPK8 and neurodevelopmental disorder.